Skip to main content
WBF What is
brain fog?
Support WBF Take quiz

Test guide Specialist assessment

Medication Review: Side Effects, Interactions, and a Safer Plan

A medication review is not a blood test or a drug blacklist. It matches everything you actually use to its reason, benefit, side effects, interactions, monitoring, and your symptom timeline. The result should be one accurate list and one agreed plan, not an instruction to stop medicines yourself.

Bring actual use Containers, photos, prescriptions, OTC products, supplements, and as-needed doses Give each item a job Reason, benefit, harm, interaction, monitoring, and practical fit No normal score The result is a reconciled list and an agreed action plan Do not change it alone Withdrawal and rebound risk make the exact plan drug-specific
01

What a medication review should answer

A review can find a wrong list, repeated ingredients, a drug with no current job, a missed safety test, a side effect, or an interaction. It can also find a dose, timing, cost, or withdrawal problem. Brain fog may be one sign. Check timing, sleep, illness, alcohol, other drugs, and the treated condition before blaming a medicine.

Current list

What are you taking now?

Resolve the name, strength, route, schedule, last dose, missed doses, recent starts and stops, duplicate ingredients, and every nonprescription product.

Purpose

Does every item still have a job?

Keep the diagnosis or symptom, expected benefit, experienced benefit, duration, and current treatment goal beside each medicine.

Safety

Could the regimen be causing harm?

Check side effects, interactions, withdrawal, allergies, kidney or liver change, monitoring, falls, driving, sleep, and care-transition errors.

Plan

What happens after the review?

Agree on what stays, what question goes to which prescriber, any test or taper, warning signs, and a date to review the outcome.

A medicine may contribute without being the only cause

Suspicious timing makes a review worth doing. The treated illness, poor sleep, pain, infection, dehydration, alcohol, other drugs, missed doses, or withdrawal can cause the same symptoms.

Save this test

Save what was changed and what happens next

Keep the true medicine list, symptom timing, findings, responsible clinician, safety plan, and follow-up together. Save the decision and whether it helped.

My Fog records information you enter. It does not check interactions, authorize a prescription change, or create a taper.

02

How age, sex, pregnancy, organ function, and daily life change the review

The review uses the same basic steps for every age and sex. Check the true list, each drug's job, benefit, harm, safety tests, and daily use. Age, body size, pregnancy, kidney or liver health, falls, swallowing, and who manages the drugs can change the plan.

Children

Use the child's current weight, age, formulation, measuring device, school or caregiver schedule, allergies, and every prescription and nonprescription product. Adult doses, adult interaction assumptions, and adult tools for stopping or reducing medicines aren't for children. A parent or caregiver can bring the containers, but the review should include the child at a level they understand.

Teenagers

Ask what teenagers actually take when away from home, at school, during sports, or at night. Include acne products, allergy medicines, pain relievers, energy products, supplements, nicotine, alcohol, cannabis, and medicines borrowed or shared. Discuss privacy and safety without blaming someone for reporting a missed dose.

Adult women and men

There is no separate male or female review score. Pregnancy possibility, contraception, menstrual bleeding, sexual side effects, fertility plans, body size, kidney or liver function, and the condition being treated may change individual decisions. Ask directly about effects that are easy to leave out of a rushed visit.

Pregnancy and breastfeeding

Review every prescription, over-the-counter product, vitamin, herb, and supplement with the obstetric and prescribing teams. Untreated illness and abrupt withdrawal can also cause harm, so do not stop a medicine only because pregnancy is possible or confirmed. With each decision, record the feeding plan and weeks pregnant or postpartum.

Older adults

Kidney or liver changes, frailty, falls, low blood pressure, dehydration, trouble swallowing or seeing labels, and several prescribers can make a review more urgent. So can recent hospital care or a high load of drugs that cause sleepiness or confusion. Follow the result after any change.

03

What to do before a medication review

Before the appointment, gather the containers or clear label photographs for everything you use. Include prescriptions, over-the-counter products, vitamins, minerals, herbs, sleep aids, antihistamines, pain products, inhalers, injections, patches, creams, eye or ear drops, and medicines used only sometimes.

For each item, list both names, strength, form, route, label directions, and what you really take. Add the time, last dose, reason, prescriber, pharmacy, start date, recent changes, missed doses, benefit, and possible harm.

Write the symptom timeline in plain words. Note changes after a medicine started, stopped, changed dose or time, or came under a new name. Add new store-bought products, supplements, alcohol, cannabis, or other drugs.

Bring recent hospital and specialist notes, blood or heart-test results, allergies, and past drug reactions. Add kidney or liver problems, pregnancy or breastfeeding, trouble swallowing or seeing labels, falls, and every prescriber and pharmacy.

Mark recent hospital, urgent-care, surgery, pregnancy, infection, dehydration, weight, diet, or kidney changes. Medication reconciliation is especially important after a care transition because a list can contain an old medicine, omit a new one, or show the wrong dose.

Do not stop, restart, split, crush, taper, or double a medicine to see if it causes thinking problems. Bring the concern to the review. Some medicines can cause dangerous withdrawal, loss of seizure control, relapse, bleeding, blood-pressure change, or other harm when changed abruptly.

Ask for enough time or a second appointment if the list is long. A rushed refill check is not the same as reviewing indication, benefit, harm, interactions, monitoring, practical use, preferences, and a written follow-up plan.

01

Reconcile the list

Compare containers, pharmacy records, discharge lists, specialist lists, and what you actually use. Resolve names, doses, duplicates, omissions, and stopped items first.

02

Give every item a job

Write the condition or symptom each medicine treats, the expected benefit, how you know whether it is helping, and whether that reason still applies.

03

Check harm and fit

Review side effects, interactions, kidney and liver function, age, pregnancy, falls, driving, sleep, alcohol or drug use, monitoring, cost, swallowing, and missed doses.

04

Agree on one plan

List what stays and what may change. Name who can approve it, any taper or test, warning signs, and the review date.

05

Update every copy

Make the agreed list match across My Fog, the prescriber, pharmacy, specialists, caregiver when relevant, and the next care transition.

04

How to understand the medication review findings

First check that the list is true and every item has a job. Then review benefit, harm, interactions, safety tests, and daily use. End with other possible causes and the exact agreed action.

List not yet reconciled

The list is incomplete, contradictory, or has not been reconciled

Do not decide that a medicine is safe, harmful, necessary, or unnecessary from this state. Resolve generic and brand names, strengths, routes, actual use, recent starts and stops, multiple prescribers, discharge changes, duplicate ingredients, and supplements first.

Reviewed regimen with no clear medicine-related problem

The checked medicines have a current reason, expected benefit, acceptable burden, required monitoring, and no clear medicine-related timing link

This supports the regimen under the conditions reviewed. It does not guarantee that no side effect or interaction exists. Keep the list current and return to other causes of brain fog if the medicine timeline does not fit.

Plausible medication-related problem

A plausible medication-related problem is identified

The problem may be a side effect, interaction, repeated ingredient, wrong dose or time, no current reason, no benefit, missed test, cost, or withdrawal. Agree on the action, authorized prescriber, safety plan, and follow-up.

Urgent reaction, overdose, withdrawal, or sudden confusion

Possible overdose, severe reaction, dangerous withdrawal, or sudden marked confusion

Get urgent help for trouble breathing, face or throat swelling, collapse, a seizure, chest pain, severe agitation, or being unable to wake. Overdose, one-sided weakness, or sudden severe confusion also needs urgent care. In the US, call 911 for danger or Poison Control at 1-800-222-1222.

Finding a problem is not the same as safely changing the medicine

The person who identifies the concern may not be the prescriber who can change it. The finished result names the owner, authorized action, taper or monitoring plan, warning signs, and review date. Without those, you're left with fear but no safe action to take.

See research details

Medication-review studies often measure drug counts, burden scores, or identified problems. Keep those outcomes separate from cognition, falls, hospitalization, mortality, and the reader's own function.

SourceA structured review is more than checking the refill list ContextNICE defines medication review as a structured, critical examination that reaches an agreement with the person, improves the impact of treatment, reduces medication-related problems, and reduces waste. The review includes the person's views, every prescribed, over-the-counter, and complementary product, safety, effectiveness, appropriateness, adverse-reaction risk, and monitoring.

Ask for the purpose of the review and the written outcome. Without a reason, benefit, concern, decision, owner, or follow-up, you have a checked list, not a finished review.

SourceThe best medication history records actual use ContextAHRQ's medication-interview guidance includes prescriptions, over-the-counter products, vitamins, herbs, supplements, inhalers, and full dose information: name, strength, formulation, dose, route, frequency, and last dose. FDA guidance also asks for the reason, instructions, and regular updates after a new prescription, changed dose, or stopped medicine.

Bring containers or photos and say what you really take, including skipped, split, borrowed, stopped, or as-needed doses. The review is less safe when the official list looks tidy but is not true.

SourceA 2025 randomized trial reduced drug-related problems, not symptoms in every patient ContextBischof 2025 randomized 220 adults taking at least eight drugs across 14 community pharmacies in Vienna; 198 completed the primary analysis. The structured review reduced the drug-related-problem measure by about 70 percent, adherence-related problems by about 60 percent, health-literacy-related problems by about 64 percent, and active ingredients by about 9 percent over the study periods.

Keep the setting and endpoint visible. This trial doesn't prove that a medication review cures brain fog, prevents hospitalization, or benefits people taking fewer medicines. The Austrian pharmacy organizations funded the trial, and several authors were employees or received pharmacy-organization funding.

SourceBetter prescribing does not guarantee better clinical outcomes ContextCarollo 2026 included 38 long-term-care studies, 22 randomized and 16 quasi-experimental. Reviews reduced medicines per resident by 0.89 within 12 months and 1.60 at 12 months or longer, and reduced potentially inappropriate medicines, but did not significantly change falls, hospitalizations, or mortality. Most studies had moderate or high risk of bias.

Treat fewer medicines or fewer possibly unsuitable ones as prescribing results, not proof of better memory, fewer falls, or longer life. Keep checking the person's own benefit, harm, function, and safety.

SourceAnticholinergic deprescribing evidence still has a clinical-outcome gap ContextGriffiths 2025 found eight hospital studies in adults aged 65 or older. Six reported lower anticholinergic burden, but only one included clinical outcomes and none examined safety. The studies were cohort or pre-post designs with follow-up up to three months.

A lower burden score may be useful, but do not promise restored cognition or safer outcomes from the score alone. Save the symptom, function, withdrawal, and clinical result after any authorized change.

SourceOne pragmatic trial found no reduction in sedative or anticholinergic load ContextJamieson 2023 randomized 363 community-dwelling adults aged 65 or older in New Zealand. At six months, a Drug Burden Index reduction of at least 0.5 occurred in 12.7 percent of controls and 12.2 percent of the intervention group, a difference of minus 0.4 percentage points with a 95 percent confidence interval from minus 7.9 to 7.0.

A pharmacist recommendation is not the same as a completed, tolerated medicine change. Keep prescriber agreement, patient preference, taper feasibility, and follow-up in the record.

SourceCurrent community deprescribing evidence supports caution, not a medicine-count target ContextHama 2026 reviewed 27 community-based studies and included nine in meta-analysis. The pooled effect on prescribing-related medicine use was minus 0.3234 with standard error 0.1378. The authors reported reductions in potentially inappropriate medicines but said long-term outcomes and scale-up across health systems remain uncertain.

Do not set a target number of medicines. Use the review to remove a specific problem, preserve needed treatment, and monitor the outcome that matters to the person.

SourceWithdrawal planning is part of the result ContextNICE says reviews of opioids, benzodiazepines, Z-drugs, gabapentinoids, and antidepressants should discuss benefit and harm of continuing, adjusting, or stopping. When withdrawal is agreed, the plan is usually slow and stepwise, with smaller reductions at lower doses unless clinical risk requires a faster approach.

Do not copy a taper from another person or a general website. Save the medicine, formulation, current dose, duration, previous attempts, withdrawal symptoms, agreed steps, prescriber, support, and contact plan.

SourceUS, UK, and Australian services use different routes ContextUS Medicare Part D plans must operate medication therapy management programs for targeted beneficiaries, and eligibility and delivery vary by plan. NHS England prioritizes structured reviews for groups including care-home residents, problematic polypharmacy, selected high-risk medicines, severe frailty, recent hospital admission or falls, and potentially addictive pain medicines. Australia's Home Medicines Review uses a GP referral, a credentialed pharmacist, a report to the doctor, and an agreed Medication Management Plan.

Ask the health plan, pharmacy, primary-care team, or GP which service is available where you get care. A pharmacy consultation can identify problems, but prescription changes still need the authorized prescriber and a follow-up plan.

05

What you can do before the medication review

You can make the review much more accurate without changing treatment yourself. The useful work is making actual use visible, preserving the reason for each medicine, and leaving with one written plan.

Make one list that is true

Use paper, a phone note, label photographs, or My Fog. Include name, strength, form, route, actual dose, time, reason, prescriber, pharmacy, start date, last dose, missed doses, stopped items, allergies, and every nonprescription product. Update it after every change.

Mark benefit and burden separately

For each item, write one thing it helps and one problem you wonder about. Include alertness, memory, balance, sleep, bowel or bladder change, appetite, sexual effects, pain, mood, work, driving, cost, swallowing, and how hard the schedule is to follow.

Use dates instead of a drug blacklist

Mark the start, stop, dose, and time changes beside the symptom. Also mark illness, poor sleep, dehydration, alcohol, cannabis, and other changes. A medicine name alone cannot show whether it caused the problem.

Check duplicate active ingredients

Compare the Drug Facts active-ingredient section on allergy, sleep, cough, cold, and pain products. Two different brand names can contain the same drug or combine sedating ingredients. Ask a pharmacist when the labels are unclear.

Leave with an owner and a date

Write what stays the same and which prescriber owns each question. Add any test or taper, warning signs, and the review date. Update the pharmacy and other clinicians after an approved change.

What a list and timeline cannot safely replace

Do not change a medicine from this record alone. Seek urgent help for trouble breathing, face or throat swelling, collapse, a seizure, chest pain, overdose, sudden confusion, one-sided weakness, or danger to anyone. In the US, call 911 for danger or Poison Control at 1-800-222-1222.

06

What to save from a medication review

Keep these together

  • Every prescription, OTC product and supplement, exact name, strength, form, route, label directions, actual use, last dose, missed doses, and stopped items
  • Reason, prescriber, pharmacy, start date, recent change, expected benefit, experienced benefit, concern, cost, and practical difficulty for each item
  • Symptom start, daily timing, sleep, illness, hydration, food, alcohol or drug context, falls, driving, work, and what changed after each medicine change
  • Allergies and past reactions, kidney and liver context, pregnancy or breastfeeding, monitoring results, interactions, duplicate ingredients, and care-transition discrepancies
  • Agreed action, authorized prescriber, taper or test plan, what stays unchanged, warning signs, who to contact, follow-up date, and the outcome after the change

Question for the visit

“Which medicine-related problem best fits the timing, what else could explain it, which item still earns its benefit and risk, and what exact authorized change or monitoring plan will we review next?”
07

Sources for Medication Review

01
FDA, Create and Keep a Medication List

US medication-list fields, prescriptions, OTC products, vitamins, supplements, updates, sharing, and safety.

02
FDA, Drug Interactions: What You Should Know

Drug, food, supplement, OTC active-ingredient, label, and pharmacist questions.

03
FDA, Pharmacists Help You Use Medicines Safely

Pharmacist role, full product disclosure, pregnancy, reactions, interactions, labels, and MedWatch.

04
AHRQ MATCH Toolkit, Patient Medication Interview

Prescription, OTC, vitamin, herb, supplement, inhaler, formulation, route, frequency, and last-dose reconciliation fields.

05
NICE NG5, Medicines Optimisation

Structured-review definition, all-age groups, person views, all products, safety, effectiveness, appropriateness, adverse reactions, and monitoring.

06
NICE NG215, Dependence and Withdrawal

Review content, shared plan, extra reviews, stopping decisions, stepwise withdrawal, monitoring, and contact plan.

07
NHS England, Structured Medication Reviews

Shared decision-making, problematic polypharmacy, priority groups, benefit and harm, and UK access.

08
CMS, Medication Therapy Management

Current US Medicare Part D MTM requirements, targeted beneficiaries, qualified providers, outcomes, and adverse-event reduction.

09
Healthdirect Australia, Home Medicines Review

GP referral, credentialed pharmacist, containers and nonoral products, home visit, report, follow-up, and Medication Management Plan.

10
Bischof et al., Frontiers in Medicine, 2025, PMID 40969807

Vienna community-pharmacy randomized trial, sample, drug-related-problem outcomes, active ingredients, follow-up, and funding limits.

11
Carollo et al., Age and Ageing, 2026, PMID 41967033

Thirty-eight-study long-term-care review, medicine and PIM reductions, null falls, hospitalization and mortality outcomes, heterogeneity, and bias.

12
Griffiths et al., Basic and Clinical Pharmacology and Toxicology, 2025, PMID 40887761

Eight-study hospital anticholinergic deprescribing review and clinical-outcome and safety gaps.

13
Jamieson et al., Journals of Gerontology Series A, 2023, PMID 36692224

New Zealand 363-person pragmatic randomized trial, Drug Burden Index threshold, null result, and implementation limit.

14
Hama et al., BMC Health Services Research, 2026, PMID 42251391

Twenty-seven-study community deprescribing review, nine-study meta-analysis, pooled prescribing effect, and long-term uncertainty.

See each claim's sources

procedure

A structured medication review examines all medicines with the person, weighs benefit and harm, checks adverse-reaction risk and monitoring, and ends with an agreed treatment plan.

interpretation

In a 2025 Austrian randomized trial of 220 adults taking at least eight drugs, a community-pharmacy review reduced measured drug-related problems, but the endpoint, setting, follow-up, and pharmacy-organization funding limit broader clinical claims.

interpretation

A 2026 review of 38 long-term-care studies found fewer medicines and potentially inappropriate medicines after medication review or deprescribing, without significant effects on falls, hospitalization, or mortality.

procedure

Reviewing dependence-forming medicines and antidepressants includes benefit and harm of continuing, adjusting, or stopping, and any agreed withdrawal plan is drug-specific, usually stepwise, and monitored.